Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation
In: Beneficial MicrobesSearch for other papers by G. Riezzo in
Current site
Google Scholar
Search for other papers by A. Orlando in
Current site
Google Scholar
Search for other papers by B. D’Attoma in
Current site
Google Scholar
Search for other papers by M. Linsalata in
Current site
Google Scholar
Search for other papers by M. Martulli in
Current site
Google Scholar
Search for other papers by F. Russo in
Current site
Google Scholar
Dysbiosis may contribute to constipation and its symptoms, therefore probiotic administration could improve significantly gut health and functions. The aim of the study was to investigate the effects of a long-lasting administration of Lactobacillus reuteri DSM 17938 (LR DSM 17938) on symptoms and quality of life (QoL) score in patients with functional constipation (FC). 56 FC patients with normal colonic transit time and without anorectal disorders and pelvic floor dysfunctions completed the study. LR DSM 17938 was administered for 105 days in a randomised double-blind clinical trial (28 patients per arm). Individual and cumulative scores including the Constipaq, a modified Constipation Scoring System (CSS) that considers the patient assessment of constipation-QoL (PAC-QoL), were calculated during the preliminary visit (V0), at day 15 (end of the induction period with a LR DSM 17938 double dosage, 4×108 cfu), day 60 (intermediate evaluation) and day 105 (V4) after a standard dosage (2×108 cfu). At the end of treatment, the beneficial effect of LR DSM 17938 compared to placebo was significantly evident for symptoms related to gas content and dysbiosis (abdominal discomfort, pain and bloating), incomplete defecation and helps for defecation (P<0.05). At the end of the whole LR DSM 17938 treatment, a marked and positive effect on both the CSS single and the cumulative items was evident with the exception of unfruitful attempt and Bristol score. Present findings indicate that LR DSM 17938 has an effect on symptoms different from stool consistency, and they suggest that this probiotic can effectively be used in association therapy rather than as single-drug therapy in the management of FC.
-
Agachan, F., Chen, T., Pfeifer, J., Reissman, P. and Wexner, S.D., 1996. A constipation scoring system to simplify evaluation and management of constipated patients. Diseases of the Colon and Rectum 39: 681-685.
'A constipation scoring system to simplify evaluation and management of constipated patients ' () 39 Diseases of the Colon and Rectum : 681 -685.
-
Altomare, D.F., Portincasa, P., Rinaldi, M., Di Ciaula, A., Martinelli, E., Amoruso, A., Palasciano, G. and Memeo, V., 1999. Slow-transit constipation: solitary symptom of a systemic gastrointestinal disease. Diseases of the Colon and Rectum 42: 231-240.
'Slow-transit constipation: solitary symptom of a systemic gastrointestinal disease ' () 42 Diseases of the Colon and Rectum : 231 -240.
-
Ashraf, W., Park, F., Lof, J. and Quigley, E.M., 1996. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. American Journal of Gastroenterology 91: 26-32.
'An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation ' () 91 American Journal of Gastroenterology : 26 -32.
-
Bassotti, G., Villanacci, V., Creţoiu, D., Creţoiu, S.M. and Becheanu, G., 2013. Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out. World Journal of Gastroenterology 19: 4099-4105.
'Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out ' () 19 World Journal of Gastroenterology : 4099 -4105.
-
Belsey, J., Greenfield, S., Candy, D. and Geraint, M., 2010. Systematic review: impact of constipation on quality of life in adults and children. Alimentary Pharmacology and Therapeutics 31: 938-949.
'Systematic review: impact of constipation on quality of life in adults and children ' () 31 Alimentary Pharmacology and Therapeutics : 938 -949.
-
Bergner, M., 1989. Quality of life, health status, and clinical research. Medical Care 27: S148-156.
'Quality of life, health status, and clinical research ' () 27 Medical Care : S148 -156.
-
Choi, C.H. and Chang, S.K., 2015. Alteration of gut microbiota and efficacy of probiotics in functional constipation. Journal of Neurogastroenterology and Motility 21: 4-7.
'Alteration of gut microbiota and efficacy of probiotics in functional constipation ' () 21 Journal of Neurogastroenterology and Motility : 4 -7.
-
Closa-Monasterolo, R., Ferre, N., Castillejo-DeVillasante, G., Luque, V., Gispert-Llaurado, M., Zaragoza-Jordana, M., Theis, S. and Escribano, J., 2017. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study. International Journal of Food Science and Nutrition 68: 587-594.
'The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study ' () 68 International Journal of Food Science and Nutrition : 587 -594.
-
Das, S., Gupta, P.K. and Das, R.R., 2016. Efficacy and safety of Saccharomyces boulardii in acute rotavirus diarrhea: double blind randomized controlled trial from a developing country. Journal of Tropical Pediatrics 62: 464-470.
'Efficacy and safety of Saccharomyces boulardii in acute rotavirus diarrhea: double blind randomized controlled trial from a developing country ' () 62 Journal of Tropical Pediatrics : 464 -470.
-
Dimidi, E., Christodoulides, S., Fragkos, K.C., Scott, S.M. and Whelan, K., 2014. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 100: 1075-1084.
'The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials ' () 100 American Journal of Clinical Nutrition : 1075 -1084.
-
Drossman, D.A. and Hasler, W.L., 2016. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 150: 1257-1261.
'Rome IV-functional GI disorders: disorders of gut-brain interaction ' () 150 Gastroenterology : 1257 -1261.
-
Enck, P., Leinert, J., Smid, M., Köhler, T. and Schwille-Kiuntke, J., 2016. Functional constipation and constipation-predominant irritable bowel syndrome in the general population: data from the GECCO study. Gastroenterology Research and Practice 2016: 3186016.
'Functional constipation and constipation-predominant irritable bowel syndrome in the general population: data from the GECCO study ', in Gastroenterology Research and Practice , () 3186016.
-
Garrigues, V., Galvez, C., Ortiz, V., Ponce, M., Nos, P. and Ponce, J., 2004. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. American Journal of Epidemiology 159: 520-526.
'Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain ' () 159 American Journal of Epidemiology : 520 -526.
-
Hatakka, K., Savilahti, E., Ponka, A., Meurman, J.H., Poussa, T., Nase, L., Saxelin, M. and Korpela, R., 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322: 1327.
'Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial ' () 322 BMJ : 1327.
-
Hayes, S.R. and Vargas, A.J., 2016. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Explore 12: 463-466.
'Probiotics for the prevention of pediatric antibiotic-associated diarrhea ' () 12 Explore : 463 -466.
-
Higgins, P.D. and Johanson, J.F., 2004. Epidemiology of constipation in North America: a systematic review. American Journal of Gastroenterology 99: 750-759.
'Epidemiology of constipation in North America: a systematic review ' () 99 American Journal of Gastroenterology : 750 -759.
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514.
'Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic ' () 11 Nature Reviews Gastroenterology and Hepatology : 506 -514.
-
Kim, E.R. and Rhee, P.-L., 2012. How to interpret a functional or motility test – colon transit study. Journal of Neurogastroenterology and Motility 18: 94-99.
'How to interpret a functional or motility test – colon transit study ' () 18 Journal of Neurogastroenterology and Motility : 94 -99.
-
Koloski, N.A., Jones, M., Wai, R., Gill, R.S., Byles, J. and Talley, N.J., 2013. Impact of persistent constipation on health-related quality of life and mortality in older community-dwelling women. American Journal of Gastroenterology 108: 1152-1158.
'Impact of persistent constipation on health-related quality of life and mortality in older community-dwelling women ' () 108 American Journal of Gastroenterology : 1152 -1158.
-
Koloski, N.A., Talley, N.J. and Boyce, P.M., 2000. The impact of functional gastrointestinal disorders on quality of life. American Journal of Gastroenterology 95: 67-71.
'The impact of functional gastrointestinal disorders on quality of life ' () 95 American Journal of Gastroenterology : 67 -71.
-
Lewis, S.J. and Heaton, K.W., 1997. Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology 32: 920-924.
'Stool form scale as a useful guide to intestinal transit time ' () 32 Scandinavian Journal of Gastroenterology : 920 -924.
-
Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F. and Spiller, R.C., 2006. Functional bowel disorders. Gastroenterology 130: 1480-1491.
'Functional bowel disorders ' () 130 Gastroenterology : 1480 -1491.
-
Lovell, R.M. and Ford, A.C., 2012. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clinical Gastroenterology and Hepatology 10: 712-721.
'Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis ' () 10 Clinical Gastroenterology and Hepatology : 712 -721.
-
Lyford, G.L., He, C.L., Soffer, E., Hull, T.L., Strong, S.A., Senagore, A.J., Burgart, L.J., Young-Fadok, T., Szurszewski, J.H. and Farrugia, G., 2002. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut 51: 496-501.
'Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation ' () 51 Gut : 496 -501.
-
Marquis, P., De La Loge, C., Dubois, D., McDermott, A. and Chassany, O., 2005. Development and validation of the patient assessment of constipation quality of life questionnaire. Scandinavian Journal of Gastroenterology 40: 540-551.
'Development and validation of the patient assessment of constipation quality of life questionnaire ' () 40 Scandinavian Journal of Gastroenterology : 540 -551.
-
Mazlyn, M.M., Nagarajah, L.H., Fatimah, A., Norimah, A.K. and Goh, K.L., 2013. Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study. Journal of Gastroenterology and Hepatology 28: 1141-1147.
'Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study ' () 28 Journal of Gastroenterology and Hepatology : 1141 -1147.
-
McMillan, S.C. and Williams, F.A., 1989. Validity and reliability of the constipation assessment scale. Cancer Nursing 12: 183-188.
'Validity and reliability of the constipation assessment scale ' () 12 Cancer Nursing : 183 -188.
-
McNeil, B.J., Weichselbaum, R. and Pauker, S.G., 1981. Speech and survival – tradeoffs between quality and quantity of life in laryngeal cancer. New England Journal of Medicine 305: 982-987.
'Speech and survival – tradeoffs between quality and quantity of life in laryngeal cancer ' () 305 New England Journal of Medicine : 982 -987.
-
Mearin, F., Ciriza, C., Minguez, M., Rey, E., Mascort, J.J., Pena, E., Canones, P. and Judez, J., 2016. Clinical practice guideline: irritable bowel syndrome with constipation and functional constipation in the adult. Revista Espanola de Enfermedades Digestivas 108: 332-363.
'Clinical practice guideline: irritable bowel syndrome with constipation and functional constipation in the adult ' () 108 Revista Espanola de Enfermedades Digestivas : 332 -363.
-
Ojetti, V., Ianiro, G., Tortora, A., D’Angelo, G., Di Rienzo, T.A., Bibbo, S., Migneco, A. and Gasbarrini, A., 2014. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. Journal of Gastrointestinal Liver Disease 23: 387-391.
'The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial ' () 23 Journal of Gastrointestinal Liver Disease : 387 -391.
-
O’Keefe, E.A., Talley, N.J., Tangalos, E.G. and Zinsmeister, A.R., 1992. A bowel symptom questionnaire for the elderly. Journal of Gerontology 47: M116-M121.
'A bowel symptom questionnaire for the elderly ' () 47 Journal of Gerontology : M116 -M121.
-
O’Keefe, E.A., Talley, N.J., Zinsmeister, A.R. and Jacobsen, S.J., 1995. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. Journal of Gerontology 50: M184-M189.
'Bowel disorders impair functional status and quality of life in the elderly: a population-based study ' () 50 Journal of Gerontology : M184 -M189.
-
Osterberg, A., Graf, W., Karlbom, U. and Pahlman, L., 1996. Evaluation of a questionnaire in the assessment of patients with faecal incontinence and constipation. Scandinavian Journal of Gastroenterology 31: 575-580.
'Evaluation of a questionnaire in the assessment of patients with faecal incontinence and constipation ' () 31 Scandinavian Journal of Gastroenterology : 575 -580.
-
Palumbo, V.D., Romeo, M., Marino Gammazza, A., Carini, F., Damiani, P., Damiano, G., Buscemi, S., Lo Monte, A.I., Gerges-Geagea, A., Jurjus, A. and Tomasello, G., 2016. The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 160: 372-377.
'The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study ' () 160 Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia : 372 -377.
-
Peppas, G., Alexiou, V.G., Mourtzoukou, E. and Falagas, M.E., 2008. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterology 8: 5.
'Epidemiology of constipation in Europe and Oceania: a systematic review ' () 8 BMC Gastroenterology : 5.
-
Preston, D.M. and Lennard-Jones, J.E., 1986. Severe chronic constipation of young women: idiopathic slow transit constipation. Gut 27: 41-48.
'Severe chronic constipation of young women: idiopathic slow transit constipation ' () 27 Gut : 41 -48.
-
Rios-Covian, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., De los Reyes-Gavilan, C.G. and Salazar, N., 2016. Intestinal short chain fatty acids and their link with diet and human health. Frontiers in Microbiology 7: 185.
'Intestinal short chain fatty acids and their link with diet and human health ' () 7 Frontiers in Microbiology : 185.
-
Rosander, A., Connolly, E. and Roos, S., 2008. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain , L. reuteri DSM 17938. Applied and Environmental Microbiology 74: 6032-6040.
'Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain , L. reuteri DSM 17938 ' () 74 Applied and Environmental Microbiology : 6032 -6040.
-
Shukla, R., Ghoshal, U., Dhole, T.N. and Ghoshal, U.C., 2015. Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis. Digestive Diseases and Sciences 60: 2953-2962.
'Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis ' () 60 Digestive Diseases and Sciences : 2953 -2962.
-
Testa, M.A. and Simonson, D.C., 1996. Assessment of quality-of-life outcomes. New England Journal of Medicine 334: 835-840.
'Assessment of quality-of-life outcomes ' () 334 New England Journal of Medicine : 835 -840.
-
Triantaf yllou, K., Chang, C. and Pimentel, M., 2014. Methanogens, methane and gastrointestinal motility. Journal of Neurogastroenterology and Motililty 20: 31-40.
'Methanogens, methane and gastrointestinal motility ' () 20 Journal of Neurogastroenterology and Motililty : 31 -40.
-
Urbanska, M. and Szajewska, H., 2014. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. European Journal of Pediatrics 173: 1327-1337.
'The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence ' () 173 European Journal of Pediatrics : 1327 -1337.
-
Van der Sijp, J.R., Kamm, M.A., Nightingale, J.M., Akkermans, L.M., Ghatei, M.A., Bloom, S.R., Jansen, J.B. and Lennard-Jones, J.E., 1998. Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation. American Journal of Gastroenterology 93: 1351-1356.
'Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation ' () 93 American Journal of Gastroenterology : 1351 -1356.
-
Wilson, I.B. and Cleary, P.D., 1995. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273: 59-65.
'Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes ' () 273 JAMA : 59 -65.
-
Wu, R.Y., Pasyk, M., Wang, B., Forsythe, P., Bienenstock, J., Mao, Y.K., Sharma, P., Stanisz, A.M. and Kunze, W.A., 2013. Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Journal of Neurogastroenterology and Motililty 25: e205-214.
'Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains ' () 25 Journal of Neurogastroenterology and Motililty : e205 -214.
-
Zhao, Y. and Yu, Y.B., 2016. Intestinal microbiota and chronic constipation. Springerplus 5: 1130.
'Intestinal microbiota and chronic constipation ' () 5 Springerplus : 1130.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 392 | 322 | 56 |
| PDF Views & Downloads | 572 | 469 | 64 |
Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation
In: Beneficial MicrobesSearch for other papers by G. Riezzo in
Current site
Google Scholar
PubMed
Search for other papers by A. Orlando in
Current site
Google Scholar
PubMed
Search for other papers by B. D’Attoma in
Current site
Google Scholar
PubMed
Search for other papers by M. Linsalata in
Current site
Google Scholar
PubMed
Search for other papers by M. Martulli in
Current site
Google Scholar
PubMed
Search for other papers by F. Russo in
Current site
Google Scholar
PubMed
Dysbiosis may contribute to constipation and its symptoms, therefore probiotic administration could improve significantly gut health and functions. The aim of the study was to investigate the effects of a long-lasting administration of Lactobacillus reuteri DSM 17938 (LR DSM 17938) on symptoms and quality of life (QoL) score in patients with functional constipation (FC). 56 FC patients with normal colonic transit time and without anorectal disorders and pelvic floor dysfunctions completed the study. LR DSM 17938 was administered for 105 days in a randomised double-blind clinical trial (28 patients per arm). Individual and cumulative scores including the Constipaq, a modified Constipation Scoring System (CSS) that considers the patient assessment of constipation-QoL (PAC-QoL), were calculated during the preliminary visit (V0), at day 15 (end of the induction period with a LR DSM 17938 double dosage, 4×108 cfu), day 60 (intermediate evaluation) and day 105 (V4) after a standard dosage (2×108 cfu). At the end of treatment, the beneficial effect of LR DSM 17938 compared to placebo was significantly evident for symptoms related to gas content and dysbiosis (abdominal discomfort, pain and bloating), incomplete defecation and helps for defecation (P<0.05). At the end of the whole LR DSM 17938 treatment, a marked and positive effect on both the CSS single and the cumulative items was evident with the exception of unfruitful attempt and Bristol score. Present findings indicate that LR DSM 17938 has an effect on symptoms different from stool consistency, and they suggest that this probiotic can effectively be used in association therapy rather than as single-drug therapy in the management of FC.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 392 | 322 | 56 |
| PDF Views & Downloads | 572 | 469 | 64 |
